Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1289 of 5804
-
New pill aims to calm stomach paralysis nausea
Symptom relief CompletedThe goal of this clinical trial is to evaluate if the study drug CIN-102 (deudomperidone) can help to decrease nausea severity associated with idiopathic gastroparesis severity in adult subjects. The main questions it aims to answer are: * To evaluate the efficacy of CIN-102 on…
Phase: PHASE2 • Sponsor: CinDome Pharma, Inc. • Aim: Symptom relief
Last updated Jul 15, 2026 00:00 UTC
-
New heart transplant drug combo aims to spare kidneys
Disease control Recruiting nowThis is a phase 2, prospective, multi-center, open-label clinical trial. Sixty-six (66) primary heart transplant recipients will be randomized (1:2) to receive either standard-of-care, tacrolimus-based immunosuppression, or a belatacept-based regimen with gradual tacrolimus withd…
Phase: PHASE2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
New combo drug aims to ease nerve pain in diabetes
Symptom relief OngoingThis study will look at the effects of CagriSema in people with both type 2 diabetes and painful diabetic peripheral neuropathy, compared to placebo. Participants will either get an active medicine or a "dummy" medicine (placebo). Which treatment participants get is decided by ch…
Phase: PHASE2 • Sponsor: Novo Nordisk A/S • Aim: Symptom relief
Last updated Jun 27, 2026 08:02 UTC
-
Home cancer injections: a new hope for myeloma patients?
Disease control Recruiting nowThe goal of this open label, phase two, prospective, non-randomized, sponsor-initiated explorative trial is to test self-administration of subcutaneous Elranatamab in the patients' homes in patients with relapsed multiple myeloma exposed to at least one proteasome inhibitor, one …
Phase: PHASE2 • Sponsor: Thomas Lund • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
New combo therapy may beat stubborn fungal infections
Disease control CompletedDermatophytosis caused by Trichophyton species is a common superficial fungal infection of the skin, hair, and nails. Increasing reports of persistent or recurrent disease after standard antifungal therapy have raised concern for treatment resistance and incomplete clearance of f…
Phase: NA • Sponsor: Multan Medical And Dental College • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
Can a targeted drug reach brain tumors? small trial aims to find out
Disease control Recruiting nowThe researchers are doing this study to find out how effective sotorasib is at getting into KRAS G12C+ brain tumors. The researchers will also find out whether sotorasib is a safe and effective treatment for people undergoing surgical resection of KRAS G12C+ metastatic brain tumo…
Phase: PHASE1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Can acceptance and compassion rewire the Brain's body image?
Symptom relief CompletedBody Dysmorphic Disorder (BDD) is a severe psychiatric condition characterized by persistent and intrusive preoccupations with perceived flaws in physical appearance, which are typically unnoticeable or appear minor to others. BDD is associated with significant psychological dist…
Phase: NA • Sponsor: University of Coimbra • Aim: Symptom relief
Last updated Jul 08, 2026 00:00 UTC
-
New study aims to boost HIV prevention in meth-using men
Prevention Recruiting nowThis is a hybrid type I randomized controlled trial to test the effectiveness of contingency management (CM) alone versus CM with motivational interviewing (MI) for optimizing entry or re-entry into the HIV prevention or care continua. A total of 400 participants will be randomiz…
Phase: NA • Sponsor: Florida International University • Aim: Prevention
Last updated Jun 27, 2026 12:30 UTC
-
Heart drug during surgery may cut deadly complication risk
Disease control Recruiting nowChronic mitral regurgitation is the most common valvular abnormality worldwide, it occurs in 10% of the general population and its prevalence increases with age. When left untreated, it can lead to left ventricular dysfunction and cause disabling symptoms (e.g., fatigue and dyspn…
Phase: PHASE4 • Sponsor: Università Vita-Salute San Raffaele • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
At-Home HPV tests could boost cervical cancer screening in border communities
Prevention Recruiting nowThe purpose of the Unidos Contra el VPH study is to help find options to screen, or check, for cervical cancer that individuals can do at home to help prevent and detect cervical cancer early. Usually, people get screened for cervical cancer with a Pap smear and human papillomavi…
Phase: NA • Sponsor: University of Texas at Austin • Aim: Prevention
Last updated Jun 27, 2026 13:06 UTC
-
New combo aims to stop cancer return after transplant
Disease control Recruiting nowThis phase Ib trial tests the safety, side effects, best dose and effectiveness of tagraxofusp in combination with azacitidine as maintenance therapy in treating patients with CD123 positive acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) after a donor (allogeneic…
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
Could a diabetes pill ease heart failure in type 1 patients?
Disease control Recruiting nowPeople with type 1 diabetes sometimes develop heart failure which can cause symptoms like breathlessness, tiredness or ankle swelling, reduced quality of life and lead to being admitted to hospital or suffering potential fatal consequences. This trial is investigating if a tablet…
Phase: PHASE2 • Sponsor: University of Dundee • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
New device aims to take the guesswork out of concussion recovery
Diagnosis Recruiting nowThis study is designed to observe HeadPulse data in concussed subjects that may have experienced a concussion via an injury down to the age of 4. Sports teams are the focus of this study because therein lies inherent potential risk for concussion. This observational study will fu…
Sponsor: MindRhythm, Inc. • Aim: Diagnosis
Last updated Jun 27, 2026 07:51 UTC
-
No squeeze, no rays: new breast cancer test could change screening
Diagnosis Recruiting nowBreast cancer predominates among cancer diagnoses in Canadian women. It accounts for around 25% of new cases and contributes to 13% of all cancer-related deaths. In 2020, almost 27,400 Canadian women were diagnosed with breast cancer and 5,000 of them died from it. Mammography i…
Sponsor: Université de Sherbrooke • Aim: Diagnosis
Last updated Jun 27, 2026 13:01 UTC
-
Sound waves and light drug target deadly brain tumors in early trial
Disease control CompletedThis trial is designed to evaluate safety and explore possible efficacy of 5-aminolevulinic acid hydrochloride (5-ALA HCl, Gliolan®) with CV01 delivery of ultrasound for sonodynamic therapy in patients with newly diagnosed high-grade glioma prior to resection and standard adjuvan…
Phase: PHASE1 • Sponsor: Universität Münster • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
Cancer patients monitored for years after experimental immune cell treatment
Disease control ENROLLING_BY_INVITATIONThe primary purpose of this study is to monitor potential long-term risks associated with the administration of SynKIR CAR T cell products.
Sponsor: Verismo Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
New pill aims to slow lung scarring in IPF patients
Disease control Recruiting nowThis clinical trial is a 2:2:1 randomized, double-blind, placebo-controlled, parallel group, exploratory phase II trial. The main objective of this trial is to compare and evaluate change in FVC compared to placebo by administering SB17170 to moderate to severe patients with IPF.…
Phase: PHASE2 • Sponsor: SPARK Biopharma • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
New asthma shot aims to cut attacks in half
Disease control Recruiting nowThis is a multicenter, randomized, masked, active and placebo controlled, Phase II clinical study to evaluate the efficacy, safety, and pharmacokinetics of LP-003 injection in adult patients with moderate to severe persistent allergic asthma.
Phase: PHASE2 • Sponsor: Longbio Pharma • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
Sleep your way to a healthier heart? new study tests sleep coaching for blood pressure
Disease control Recruiting nowImproving multiple domains of cardiometabolic health (CMH) through contextual behavioral interventions has the potential to substantially reduce persistent chronic disease disparities. Sleep is critical for preserving CMH and is amenable to intervention in real-world settings. Al…
Phase: NA • Sponsor: Columbia University • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Poop pills and fiber: new hope for bone marrow transplant complications?
Disease control Recruiting nowThis phase I trial studies how well fecal microbiota transplant and dietary fiber supplementation work in treating patients with gut graft versus host disease. Fecal microbiota transplant entails inoculating donor stool into a recipient's gastrointestinal tract. Changing the gut …
Phase: PHASE1 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC